DR. FRANCESCO PAOLO PILATO President and CEO, founder of Bio3 Research
Former senior executive in the pharmaceutical and diagnostic industry with broad experience in the international arena (VP International Activities with Serono, Board Member with Menarini Group, VP in Bracco Group, Director and Chairman of several Bracco Group entities) more...
DR. FEDERICO GARDINI Chief Business Officer
Mr. Gardini, Bio3 Research Chief Business Officer, graduated from the Luigi Bocconi University of Milan with a degree in Business Management.
After the opening of Bio3 Research Inc. (Hayward/CA), Mr. Gardini has also been appointed General Operations Manager of the Californian subsidiary. Mr. Gardini will manage the operations from Bio3 Research S.r.l. in Italy.
DR. GABRIELLA MESSINA Head Special Projects and Logistic
Graduated in Modern Literature and expert in administrative and HR management. Ms. Messina in her career has covered different responsibilities in High Schools and Universities. She has also taught Italian language and literature at the Boston University.
DR. KONSTANTIN LEVITSKY Director of Research and Development at Bio3 Research Inc.
Dr. Konstantin Levitsky is Director of Research and Development at Bio3 Research Inc. Dr. Levitsky received his doctoral degree in Biochemistry from the University of Wisconsin – Madison and has more than 10 years of experience in protein biochemistry, assay development and project management with small molecules and protein therapeutics. Prior to joining Bio3 Research, Dr. Levitsky held positions at Proteolix Inc. (South San Francisco, CA) and Bayer HealthCare Pharmaceuticals (Richmond, CA) where he worked on wide-ranging efforts from irreversible inhibitors of several enzymes, to protein engineering of steroid receptors for target discovery and gene therapy applications.
DR. BRUCE LANDAY Legal Counsel (Boston)
Mr. Landay graduated from Yale University (B.A. 1983 cum laude) and Georgetown University (J.D. 1987). He was admitted to the bars of New York, Massachusetts and Washington, DC in 1988. After a brief experience as a visiting foreign lawyer at an Italian law firm (now Allen & Overy Italy), Mr. Landay was an associate at Oppenheimer Wolff & Donnelly in Washington and Palmer & Dodge in Boston. He has been a partner in the firm of Landay & Leblang since 1994.
Collaborations
GUIDO CAPPUCCILLI Bio3 Research Consultant for Mimic Abs anti-HMGB1 and for SiRNA HMGB1 specific Projects.
Dr. Guido Cappuccilli, Bio3 Research Consultant for Mimic Abs anti-HMGB1 and for SiRNA HMGB1 specific Projects, is the Chief bioinformatics Scientist at ProtElix (CA/USA). He earned his Bioengineering doctoral degree in 2000 at the University of Bologna (Italy). Prior to joining ProtElix he was Bioinformatics Scientist at BioRen (acquired by Pfizer in August 2005).
Dr. Cappuccilli expertise and skills are established in the areas of knowledge discovery and information extraction from biological databases, computational design of mutagenesis libraries, creating statistical programs for protein optimization, bioinformatics software development, invention of improved methods of protein mutagenesis. He is author/co-author of more than ten patents/patent applications.
VINCENZO MARCO PILATO Media Production and Communication Consultant
Msc in Animation and Modelling at Academy
of ArtSan FranciscoCA,USA. Bsc Multimedia Technology at Kent University, Canterbury, UK and Msc in Computer Animation at Kent University. Consulting and working on improving the company and its products presentations. Working on the graphic, 3D and Art side of the company to further enhance the companies multimediality. In charge of creating an animation short to promote Bio3 Research.
Bio3 News...
Bio3 Research has recently been granted from USPTO the
US
patent # 10/471,641 which claims the use of HMGB1 inhibitors and antagonists for
the treatment of Cardiovascular Disorders…